| __timestamp | Intra-Cellular Therapies, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 4167274 |
| Thursday, January 1, 2015 | 139626 | 5247851 |
| Friday, January 1, 2016 | 93831530 | 4925118 |
| Sunday, January 1, 2017 | 79419009 | 14930297 |
| Monday, January 1, 2018 | 368673 | 25371768 |
| Tuesday, January 1, 2019 | 477121 | 23921274 |
| Wednesday, January 1, 2020 | 1895029 | 25338236 |
| Friday, January 1, 2021 | 8034589 | 20182966 |
| Saturday, January 1, 2022 | 20443000 | 17562000 |
| Sunday, January 1, 2023 | 33745000 | 25212000 |
Data in motion
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. Intra-Cellular Therapies, Inc. and Pharming Group N.V. have shown contrasting trends in their cost of revenue from 2014 to 2023. Intra-Cellular Therapies, Inc. experienced a significant fluctuation, with a peak in 2016, where costs surged by over 400% compared to 2015. However, by 2023, they managed to stabilize, achieving a 60% reduction from their 2016 high. On the other hand, Pharming Group N.V. demonstrated a more consistent trajectory, with a steady increase in costs, peaking in 2020. Despite this, they maintained a more controlled growth, with only a 20% increase from 2014 to 2023. This comparison highlights the diverse strategies and challenges faced by these companies in managing their cost structures over the years.
Analyzing Cost of Revenue: Novo Nordisk A/S and Intra-Cellular Therapies, Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Pharming Group N.V.
GSK plc vs Intra-Cellular Therapies, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Incyte Corporation and Pharming Group N.V.'s Expenses
BioMarin Pharmaceutical Inc. vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Pharming Group N.V. vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Pharming Group N.V. and Perrigo Company plc
Cost of Revenue Comparison: Pharming Group N.V. vs Veracyte, Inc.
Cost of Revenue Trends: Pharming Group N.V. vs HUTCHMED (China) Limited
Cost Insights: Breaking Down Pharming Group N.V. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Pharming Group N.V. vs Evotec SE